You are here

  • Home
  • Archive
  • Volume 15, Issue 1
  • High efficacy of HPV 16/18 AS04-adjuvanted vaccine shown against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types

Article info

Article menu
Download PDFPDF
Therapeutics
PATRICIA randomised controlled trial
High efficacy of HPV 16/18 AS04-adjuvanted vaccine shown against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types

Authors

  1. Lisa Rambout
    Division of Gynaecologic Oncology, Department of Pharmacy, The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6; lrambout{at}toh.on.ca
View Full Text

Citation

Rambout L
High efficacy of HPV 16/18 AS04-adjuvanted vaccine shown against CIN2+ associated with HPV-16/18 and non-vaccine oncogenic HPV types
BMJ Evidence-Based Medicine 2010;15:7-8.

Publication history

  • First published February 22, 2010.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions